ライフサイエンスコーパス: hip bone

1 T9-L5 vertebrae and the ilium portion of the hip bones.

2 r without low BMD underwent lumbar spine and hip bone densitometry and a complete periodontal examina

3 Lateral lumbar spine and hip bone density remained stable or improved in 65% and

4 Hip bone density was 1.06 percent higher in the calcium

5 ding influences of age, body mass index, and hip bone density were taken into account.

6 ed in a small but significant improvement in hip bone density, did not significantly reduce hip fract

7 AIDs or mild anemia and question the use of hip bone-derived cells as healthy experimental controls.

8 Living inhabitants of the hip bone (e.g. osteocytes) are visible in their local ex

9 variation in bone mineral density (BMD) and hip bone geometry are associated with fracture risk.

10 iation between dietary patterns, measures of hip bone geometry, and subsequent fracture risk are scar

11 TATE was observed in the T9-L5 vertebrae and hip bones in all 17 patients compared with activity conc

12 men, PAD was associated with higher rates of hip bone loss and increased risk of nonspine fractures.

13 one mineral density at the hip and the heel, hip bone loss over 2 years, and fractures during 3.5 yea

14 Total-body and hip bone mineral content (BMC) and bone mineral density

15 intake during childhood and adolescence and hip bone mineral content and bone mineral density (P < 0

16 scence was associated with a 3% reduction in hip bone mineral content and bone mineral density (P < 0

17 oints were changes in lumbar spine and total hip bone mineral densities (BMDs); secondary endpoints w

18 3.72%, 95% CI 1.54 to 5.89; p=0.26), nor did hip bone mineral density (2.09%, 95% CI -1.45 to 5.63 vs

19 yunsaturated fatty acid and fish intakes and hip bone mineral density (BMD) at baseline (1988-1989; n

20 mary endpoint was percentage change in total hip bone mineral density (BMD) from baseline to week 48

21 A candidate locus for regulation of hip bone mineral density (BMD) has been identified on ch

22 The database includes spine and hip bone mineral density (BMD) in 1056 premenopausal or

23 Lumbar spine and total hip bone mineral density (BMD) were assessed at baseline

24 The primary outcome was total hip bone mineral density (BMD), with femoral neck BMD, l

25 The primary outcome measure was total hip bone mineral density (BMD); secondary measures were

26 ty, followed up prospectively for changes in hip bone mineral density and fractures.

27 percentage changes in lumbar spine and total hip bone mineral density at week 48, assessed by dual en

28 y for a treat-to-target approach, with total hip bone mineral density being the best specific target.

29 howed a smaller decrease in lumbar spine and hip bone mineral density but greater accumulation of lim

30 Participants were stratified by spine and hip bone mineral density categories.

31 Adjustment for total-hip bone mineral density eliminated the elevated risk.

32 ne mineral density secondary outcomes, total hip bone mineral density increased more in the teriparat

33 Hip bone mineral density increases were greater with TAF

34 Total hip bone mineral density loss was similarly greater at w

35 measured by peripheral quantitative CT, and hip bone mineral density measured by dual-energy X-ray a

36 /d and was not associated with total body or hip bone mineral density measurements.

37 years or more, with a femoral neck or total hip bone mineral density T-score between -2.5 and -4.0 i

38 2]; p<0.0001), and mean percentage change in hip bone mineral density was 1.33% (2.20) in the elviteg

39 c effect of weight change on change in total hip bone mineral density was evaluated over 4 years (199

40 Hip bone mineral density was measured with dual x-ray ab

41 th differences in percentage change in total hip bone mineral density were 0.79 percentage point (95%

42 change from baseline to week 48 in spine and hip bone mineral density with a null hypothesis of zero

43 n (serum type I collagen C-telopeptide), low hip bone mineral density, absence of urticaria pigmentos

44 We assessed ankle-brachial index and hip bone mineral density, followed up prospectively for

45 els adjusted for age, body mass index (BMI), hip bone mineral density, knee surgery or pain, and phys

46 cs sex, serum type I collagen C-telopeptide, hip bone mineral density, urticaria pigmentosa, and alco

47 022 Gy/GBq for the mean of all vertebrae and hip bones, respectively.

48 0.069 +/- 0.033 Gy/GBq for the vertebrae and hip bones, respectively.

49 THA-derived hip bones serve as a major source of healthy hematopoiet

50 e in areal BMD of the lumbar spine and total hip, bone turnover markers C-terminal telopeptide cross-